Grey
Brand Name(s):TOOKAD
Indication:Cancer -adenocarcinoma of the prostate
Rationale:1
Considered:Aug-18
Review Date:Jan-24
Comments:
NICE TA546
Padeliporfifin for untreated localised
prostate cancer
Nov 18
Brand Name(s):TOOKAD
Indication:Cancer -adenocarcinoma of the prostate
Rationale:1
Considered:Aug-18
Review Date:Jan-24
Comments:
NICE TA546
Padeliporfifin for untreated localised
prostate cancer
Nov 18